Status:
COMPLETED
A Pilot and Feasibility Study of Mobile-Based Asthma Action Plans
Lead Sponsor:
Arkansas Children's Hospital Research Institute
Collaborating Sponsors:
University of Arkansas
Conditions:
Asthma
Eligibility:
All Genders
12-17 years
Phase:
NA
Brief Summary
Investigators from University of Arkansas for Medical Sciences Department of Pediatrics and University of Arkansas for Medical Sciences Center for Distance Health will collaborate to develop a mobile-...
Detailed Description
A written Asthma Action Plan from a healthcare provider is one of the key features of asthma self-management recommended by the National Asthma Education and Prevention Program asthma guidelines; guid...
Eligibility Criteria
Inclusion
- Age ≥ 12 and ≤ 17 years.
- Mild to severe persistent asthma or poorly controlled asthma. If a child has used a preventive medication in the past, but reports no use of the medication in the prior 3 months, we will assess severity.
- Children not using a preventive medication at baseline: We will assess for mild persistent to severe persistent asthma. Any one of the following, during the prior 4 weeks (as defined by parent interview) will determine severity:
- An average of \>2 days per week with asthma symptoms
- \>2 days per week with rescue medication use
- ≥2 nights per month awakened with nighttime symptoms
- Minor limitation of activity
- ≥2 episodes of asthma during the past year that have required systemic corticosteroids.
- Children using a preventive medication at baseline: We will assess for poorly controlled asthma. Any 1 of the following, during the prior 4 weeks (as defined by parent interview in the waiting room) will determine control:
- An average of \>2 days per week with asthma symptoms
- \>2 days per week with rescue medication use
- ≥2 nights per month awakened with nighttime symptoms
- Some limitation of activity
- ≥2 episodes of asthma during the past year that have required systemic corticosteroids.
Exclusion
- Significant underlying respiratory disease other than asthma (such as cystic fibrosis or chronic lung disease) that could potentially interfere with asthma-related outcome measures.
- Significant co-morbid conditions (such as moderate to severe developmental delay, i.e. special education classroom or diagnosis) that could preclude participation in an education-based intervention.
- Inability to speak or understand English (child or parent).
- Children in foster care or other situations in which consent cannot be obtained from a guardian.
- Prior enrollment in the study.
Key Trial Info
Start Date :
June 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT01514760
Start Date
June 1 2012
End Date
October 1 2013
Last Update
October 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arkansas Children's Hospital Research Institute
Little Rock, Arkansas, United States, 72202